Articles in section Quarterly Review
<< Pfizer | 11 articles | Roche >> |
Pages 1 2 | Next >> |
-
AstraZeneca Ramps Up Deal-Making Activity
-
Roche, GSK and Pfizer Remain the Most Prolific Big Pharma Dealmakers
-
GSK Moves up the M&A Rankings
-
Sanofi Climbs the Deal Activity League Table
-
Big Pharma Increasingly Pursues Long-Term Deal Investment
-
Roche Ends 2011 as the Leading Big Pharma Dealmaker
-
Pfizer’s Deal Activity Ranking Improves but Roche Still Leads
-
Pfizer and GSK Swap Places in PharmaDeals Corp-METRx Deal Activity League Table
-
12 Month Rankings
-
Monthly Review September 2011